Brown, Lisle/Cummings’s Marex Group Limited Ordinary Shares MRX Stock Holding History

Brown, Lisle/Cummings’s Portfolio MRX Stock Details MRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.5K	Buy	+56	New	+$2.21K	﹤0.01%	780

Other funds holding MRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown, Lisle/Cummings's MRX Position: Q1 2026 in Review

Brown, Lisle/Cummings opened a new position in Marex Group Limited Ordinary Shares (MRX) in Q1 2026: 56 shares worth $2.5K. The stake represents ﹤0.01% of the portfolio and ranks #780 among its holdings.

205 funds tracked by Wall St. Rank hold MRX as of Q1 2026.

Brown, Lisle/Cummings held 56 shares of Marex Group Limited Ordinary Shares worth $2.5K as of Q1 2026.
Marex Group Limited Ordinary Shares was a new Brown, Lisle/Cummings position in Q1 2026.
Marex Group Limited Ordinary Shares made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #780 holding.
205 funds tracked by Wall St. Rank held Marex Group Limited Ordinary Shares as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.